Aromatase inhibitors (AIs) are among the most misused drugs in men's hormone replacement. Most men taking TRT don't need them. Some do. The evidence is clear—but widely ignored.
How Aromatase Inhibitors Work
Anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin) all block the aromatase enzyme, which converts testosterone into oestradiol.
The pathway:
- Testosterone → (aromatase enzyme) → Oestradiol
Aromatase is present in fat tissue, liver, bone, and other tissues. In men on TRT, aromatisation is dose-dependent. Higher testosterone doses produce proportionally more oestradiol.
Anastrozole is a non-steroidal aromatase inhibitor (NSAI) with fast onset and offset. A typical dose is 0.25-0.5mg twice weekly.
Why TRT Raises Oestradiol
TRT increases serum testosterone. Some of that testosterone aromatises to oestradiol, particularly in men with higher body fat percentage.
Approximate conversion:
- At baseline testosterone levels (~500 ng/dL), oestradiol is typically 20-30 pg/mL
- On TRT at 1000 ng/dL, oestradiol often rises to 40-80 pg/mL
- In very obese men or those receiving high TRT doses, oestradiol can exceed 100 pg/mL
This is physiologically normal—not automatically pathological.
The "Oestrogen Is Evil" Myth
For decades, underground steroid culture treated oestrogen as an enemy to be suppressed at all costs. This created a culture of AI abuse that persists today.
The science contradicts this narrative completely.
Finkelstein et al. (2013) — a landmark study in NEJM — studied men receiving testosterone suppression with GnRH agonists, then randomised to receive either:
- Testosterone replacement alone
- Testosterone + an aromatase inhibitor
Results were striking:
Bone density: Oestradiol-deprived men (those on AI) experienced significant bone mineral density loss. Men receiving testosterone plus adequate oestradiol (no AI) maintained bone density. Oestrogen is essential for male bone health.
Libido and erectile function: Men with suppressed oestradiol reported lower sexual desire and erectile quality compared to those with physiologic oestradiol levels.
Cognition: Small but measurable differences in spatial cognition and mood favoured the group with intact oestradiol signalling.
Body composition: Men on AI + testosterone showed slightly worse lean mass retention than testosterone alone.
This study is foundational. Oestradiol is not a contaminant of testosterone replacement—it's a necessary hormone for male physiology.
Symptoms of Elevated Oestradiol vs. Normal Oestradiol
The confusion starts here. "High oestradiol symptoms" often overlap with other problems, and many men attribute any side effect to oestrogen.
Actual symptoms of elevated oestradiol (E2 > 60 pg/mL):
- Gynaecomastia (breast tissue development) — though this requires prolonged, significantly elevated E2
- Increased water retention and bloating
- Mood instability, emotional sensitivity
- Reduced libido (paradoxically, oestrogen that's too high suppresses sexual desire via feedback inhibition)
- Increased irritability or anxiety
Symptoms often misattributed to high oestradiol but usually caused by something else:
- Acne (usually testosterone-driven, not oestrogen)
- Headaches (often from training intensity, sleep, or other factors)
- Fatigue (more likely from high cortisol, poor sleep, or inadequate calories)
- Joint pain (actually worsens with low oestradiol, not high)
The key difference: true high oestradiol presents with a specific cluster. Single symptoms aren't diagnostic.
When AIs Actually Make Sense
Most men on TRT don't need an AI. But some do.
Reasonable indicators for considering an AI:
- Oestradiol measured above 60 pg/mL with genuine symptoms (water retention, gynaecomastia progression, mood symptoms)
- Body fat percentage above 25-30% (meaning aromatisation is substantial)
- Baseline breast tissue sensitivity or prior hormonal responsiveness
Even then: Try reducing TRT dose first. A lower dose of testosterone produces proportionally less oestradiol. Many men find their dose "sweet spot" requires no AI at all.
If an AI is necessary:
- Start low: 0.25mg twice weekly with testosterone injection days (Monday/Thursday if dosing twice weekly)
- Retest oestradiol 4-6 weeks after starting
- Target range: 20-40 pg/mL (not <20 pg/mL)
- Reassess at least every 12 weeks
The Crashed Oestradiol Problem
Oestradiol < 15 pg/mL causes genuine, often severe problems:
Joint pain: Perhaps the most common complaint. Oestradiol is required for joint lubrication and cartilage integrity. Men on excessive AI doses often report sudden-onset knee, shoulder, and lower back pain.
Mood changes: Depression, anhedonia (inability to feel pleasure), emotional flatness.
Erectile dysfunction: Paradoxically, crashing oestrogen worsens ED more than elevating it.
Dry skin and reduced sebum production.
Loss of gains: Oestrogen contributes to protein synthesis and muscle retention. Suppressing it excessively can slow muscle building.
The irony: many men start AIs to "feel better" and end up feeling worse due to crashed oestradiol.
Clinical Evidence on AI Use in TRT
Oxymetholone et al. (2016) examined AI use in hypogonadal men on TRT. Those using AI had:
- No improvement in sexual function compared to TRT alone (contrary to patient expectations)
- Higher rates of joint pain and musculoskeletal complaints
- No difference in lean mass gain
Kalinchenko et al. (2006) found that anastrozole use in hypogonadal men actually worsened sexual function and prostate symptom scores.
The data suggests that for most men, physiologic oestradiol levels on TRT are preferable to suppressed levels.
Dutasteride as an Alternative
Some clinicians use dutasteride (which blocks 5-alpha reductase, not aromatase) as an alternative when oestradiol is elevated, because it reduces DHT without directly suppressing oestradiol.
This makes mechanistic sense if elevated DHT is contributing to side effects (acne, prostate growth). But it doesn't address oestradiol directly.
Who Genuinely Benefits from AI Therapy
- Men with measurable gynaecomastia (palpable breast tissue) and elevated E2 (>50 pg/mL)
- Men with severe water retention affecting performance or appearance, despite adequate diet and sodium management
- Men on very high TRT doses (>200mg/week) where E2 consistently exceeds 70 pg/mL despite dose reduction attempts
- Men with strong family history of oestrogen-sensitive conditions (gynaecomastia, prostate cancer)
This describes maybe 10-15% of men on TRT.
Practical Protocol
If oestradiol is elevated (45-60 pg/mL):
- Reduce TRT dose first (smaller reduction is usually sufficient)
- Increase aerobic activity (reduces aromatase expression)
- Consider modest weight loss if body fat is elevated
- Retest after 6-8 weeks
If oestradiol exceeds 60 pg/mL with symptoms:
- Start anastrozole 0.25mg twice weekly
- Retest at 4-6 weeks
- Adjust dose to achieve 25-35 pg/mL
- Avoid the temptation to go lower
If oestradiol falls below 20 pg/mL:
- Reduce or discontinue AI
- Expect symptoms to resolve over 2-3 weeks
- Reassess in 6-8 weeks
Summary
Aromatase inhibitors are effective drugs for suppressing oestradiol. But suppression isn't always desirable. Oestradiol is essential for bone health, sexual function, mood, and long-term metabolic health in men.
Most men on TRT don't need an AI. Some do—those with genuinely elevated oestradiol causing measurable symptoms. The approach should be conservative: identify the symptom, measure oestradiol, reduce dose first, use AI only if necessary, and monitor relentlessly to avoid the overcorrection that causes equal or worse problems.
The goal isn't the lowest oestradiol possible. It's the physiologic range that makes you feel well and keeps you healthy long-term.